In short
Cipepofol, also known as HSK3486, is an innovative drug currently being studied in clinical trials for its potential use in general anesthesia. These trials aim to evaluate its effectiveness and safety in both adult and pediatric patients undergoing elective surgery. The research focuses on optimizing dosage, understanding its effects, and comparing it to existing anesthesia medications.
At a glance
- Drug Name
- Cipepofol (HSK3486)
- Purpose
- General anesthesia during elective surgery
- Study Types
- Multi-center, randomized, open-label clinical studies
- Patient Groups
- Adults and pediatric patients
- Administration Method
- Target-controlled infusion (TCI)
- Key Objectives
- Optimize TCI model, evaluate efficacy and safety, compare with existing anesthetics
- Primary Outcomes
- Success rate of anesthesia, optimization of TCI model parameters
- Comparison Drug
- Propofol (in pediatric study)
What is Cipepofol?
Cipepofol is a new medication being studied for use in general anesthesia for children undergoing planned (elective) surgeries. General anesthesia is a state of controlled unconsciousness that prevents a patient from feeling pain during surgery. It's important to note that Cipepofol is still in the research phase and is not yet approved for regular use.
Purpose of the Study
Researchers are conducting a Phase III clinical trial to evaluate how well Cipepofol works and how safe it is for children. A Phase III trial is typically one of the final stages before a drug can be approved for widespread use. This study is: Multicenter: It's being conducted at multiple hospitals or clinics Open: Both the doctors and patients know which treatment is being used Controlled: Cipepofol is being compared to another anesthetic drug
How Cipepofol is Used
In this study, Cipepofol is given as an injection in two stages: Induction: A dose of 0.6±0.2 mg/kg is given to start the anesthesia. This means the dose can range from 0.4 to 0.8 mg for every kilogram of the child's weight. Maintenance: A continuous dose of 0.8 mg/kg/h is given to keep the child asleep during surgery. This means for every kilogram of the child's weight, 0.8 mg of Cipepofol is given each hour.
Comparison with Propofol
The study compares Cipepofol to another anesthetic drug called Propofol. Propofol is a widely used anesthetic in both adults and children. In this study, Propofol is given at different doses: Induction: 3.0 mg/kg Maintenance: 5.0 mg/kg/h Comparing these two drugs helps researchers understand if Cipepofol is as effective and safe as the currently used Propofol.
Measuring Success
The main goal of this study is to measure the success rate of anesthesia with Cipepofol. This includes how well it works for: Anesthesia induction: How effectively it puts the child to sleep at the start of surgery Anesthesia maintenance: How well it keeps the child asleep during the entire surgery The researchers will check this success rate 24 hours after the end of surgery. This allows them to assess not just how well the anesthesia worked during the operation, but also any immediate after-effects.
Importance for Patients
This study is important for young patients and their families because it may lead to a new option for anesthesia in children's surgeries. If Cipepofol proves to be safe and effective, it could provide doctors with another tool to help keep children comfortable and safe during operations. However, it's crucial to remember that more research is needed before Cipepofol can be widely used, and the results of this study will help determine its future in pediatric anesthesia.